Taurine Protects Doxorubicin-Induced Hepatotoxicity via Its Membrane-Stabilizing Effect in Rats

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Doxorubicin (dox) is a vital chemotherapy drug, but its use is limited by organ toxicities.
• Taurine, a known antioxidant, was investigated for its protective effects against doxorubicin-induced liver damage.

Purpose of the Study:

• To investigate the protective mechanism of taurine against doxorubicin-induced hepatotoxicity.
• To determine if taurine's protective effects are mediated by its antioxidant properties or other mechanisms.

Main Methods:

• Male Sprague-Dawley rats were divided into four groups: control, taurine only, doxorubicin only, and taurine + doxorubicin.
• Doxorubicin was administered intraperitoneally over three days.
• Biochemical and histological analyses of liver tissues were performed on day 15.

Main Results:

• Doxorubicin significantly increased liver enzymes and caused histological damage.
• Taurine treatment preserved liver morphology but did not improve oxidative stress markers.
• These results suggest taurine's protective effect is not primarily due to radical scavenging.

Conclusions:

• Taurine effectively prevents doxorubicin-induced hepatotoxicity.
• The protective mechanism of taurine involves non-antioxidant pathways, likely membrane stabilization.